| Breast Cancer |
1 |
1 |
| Metastasis |
0 |
0.79 |
| Genomic Medicine |
0 |
0.66 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.51 |
| Cancer |
0 |
0.51 |
| HIV Infection |
0 |
0.51 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.51 |
| Breast |
0 |
0.43 |
| Aromatase Inhibitors |
0 |
0.41 |
| Chemotherapy |
0 |
0.22 |
| Hematology |
0 |
0.14 |
| Liver Tumor |
0 |
0.08 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Liver |
0 |
0.07 |
| Lung |
0 |
0.07 |
| Pennsylvania |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Salary and Compensation |
0 |
0.07 |
| Tumor |
0 |
0.07 |